American Society of Hematology

SHERPA: Blue

People

  1. Noy
    Noy
  2. Owens
    Owens
  3. Palomba
    Palomba
  4. Seshan
    Seshan
  5. Zelenetz
    Zelenetz
  6. Batlevi
    Batlevi
  7. Caron
    Caron
  8. Hamilton
    Hamilton
  9. Hamlin
    Hamlin
  10. Horwitz
    Horwitz

Groups

  1. CTCR Scholars (9)
  2. Center for Hematologic Malignancies (9)
  3. Center for Pancreatic Cancer Research (9)
  4. Department of Medicine (9)
  5. Hematologic Malignancies, Division of (9)
  6. MSK Grad Students (9)
  7. Master of Science in Clinical and Translational Cancer Research (9)
  8. Sloan Kettering Institute Postdocs (9)
  9. Survivorship Research (9)
  10. Biostatistics Service (8)
Search Within
  1. "Center for Pancreatic Cancer Research"
  2. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (6)
  2. Journal Article (3)
Groups
  1. CTCR Scholars (9)
  2. Center for Hematologic Malignancies (9)
  3. Center for Pancreatic Cancer Research (9)
  4. Department of Medicine (9)
  5. Hematologic Malignancies, Division of (9)
  6. MSK Grad Students (9)

More Groups

People
  1. Andrew Zelenetz (6)
  2. Ariela Noy (6)
  3. Colette Owens (6)
  4. Maria Palomba (6)
  5. Venkatraman Seshan (6)
  6. Ahmet Dogan (5)

More People

Years
  1. 2023 (1)
  2. 2021 (3)
  3. 2020 (3)
  4. 2019 (2)
Publications
  1. Blood (8)
  2. Blood Advances (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world outcomes in patients with transformed follicular lymphoma treated with CD19-targeting CAR-T therapy
    Meeting Abstract

    Rivas-Delgado, A.; Luttwak, E.; Drill, E.; Goldstein, I.; Landego, I.; Tomas, A. A.; Parascondola, A.; Saldia, A.; Caron, P.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Interim efficacy analysis of a phase II study demonstrates promising activity of the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S.; Biggar, E.; Moskowitz, A. J.; Joffe, E.; Khan, N.; Straus, D. J.; Kumar, A.; Zelenetz, A. D.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors
    Journal Article

    Dunbar, A.; Bolton, K. L.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J.; Kelly, D.; Farina, M.; Cordner, K. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era
    Journal Article

    Bobillo, S.; Joffe, E.; Lavery, J. A.; Sermer, D.; Ghione, P.; Noy, A.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Interim analysis from a prospective multicenter study of next-generation sequencing minimal residual disease assessment and CT monitoring for surveillance after frontline treatment in diffuse large B-cell lymphoma
    Meeting Abstract

    Kumar, A.; Westin, J.; Schuster, S. J.; Nowakowski, G. S.; Lossos, I. S.; Batlevi, C. L.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • TCR repertoires in graft-versus-host-disease (GVHD)-target tissues reveals tissue specificity of the alloimmune response
    Meeting Abstract

    DeWolf, S.; Nichols, K.; Nguyen, C. L.; Giardina, P. A.; Slingerland, J. B.; Elias, H.; Kappangantula, R.; Baez, P.; Murali, R.; Hayashi, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
    Journal Article

    Sermer, D.; Bobillo, S.; Dogan, A.; Zhang, Y.; Seshan, V.; Lavery, J. A.; Batlevi, C.; Caron, P.; Hamilton, A.; Hamlin, P.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Central nervous system prophylaxis with high-dose intravenous methotrexate or intrathecal chemotherapy in patients with diffuse large B-cell lymphoma and high-risk of CNS relapse treated in the rituximab era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Seshan, V.; Noy, A.; Horwitz, S. M.; Palomba, M. L.; Matasar, M. J.; Straus, D. J.; Hamlin, P. A.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Extended mutational profiling by MSK-IMPACT™ identifies mutations predicting thromboembolic risk in patients with solid tumor malignancy
    Meeting Abstract

    Dunbar, A.; Bolton, K.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J. M.; Kelly, D.; Farina, M.; Kishore, S.; more...
    Blood (2019)

    Fulltext@MSK | Save